Naked reverse: unexpected plays for exceptional results

Following the herd is easy when it comes to business ventures. But if you really want to start something new, you must first carefully think it through. Learn some ways to do that before you set out on a new path.     

内蒙古专业技术人才需求类型分析

一、模型的选择灰关联熵分析是在灰关联分析基础上发展的方法.灰色关联是指事物之间的不确定关联,或系统因子之间,因子对主行为之间的不确定关联.灰色关联简称为灰关联.灰关联分析方法是一种研究少数据、贫信息、不确定性问题的方法,其基本任务是分析和确定因子间的影响程度或因子对主行为的贡献测度,该方法依据统计数列的几何关系或曲线的相似程度来判断因素间的关联程度,几何形状越接近,则关联程度越大.灰关联分析方法无论样本量多少或有无典型的分布规律都可以适用,而且计算量小,计算十分简便,一般不会出现量化结果与定性分析结果不符合的情况.     

Why a Bayesian approach to safety analysis in pharmacovigilance is important

Large databases of routinely collected data are a valuable source of information for detecting potential associations between drugs and adverse events (AE). A pharmacovigilance system starts with a scan of these databases for potential signals of drug-AE associations that will subsequently be examined by experts to aid in regulatory decision-making. The signal generation process faces some key challenges: (1) an enormous volume of drug-AE combinations need to be tested (i.e. the problem of multiple testing); (2) the results are not in a format that allows the incorporation of accumulated experience and knowledge for future signal generation; and (3) the signal generation process ignores information captured from other processes in the pharmacovigilance system and does not allow feedback. Bayesian methods have been developed for signal generation in pharmacovigilance, although the full potential of these methods has not been realised. For instance, Bayesian hierarchical models will allow the incorporation of established medical and epidemiological knowledge into the priors for each drug-AE combination. Moreover, the outputs from this analysis can be incorporated into decision-making tools to help in signal validation and posterior actions to be taken by the regulators and companies. We discuss in this paper the apparent advantage of the Bayesian methods used in safety signal generation and the similarities and differences between the two widely used Bayesian methods. We will also propose the use of Bayesian hierarchical models to address the three key challenges and discuss the reasons why Bayesian methodology still have not been fully utilised in pharmacovigilance activities.     

Proportional hazards regression with interval censored data using an inverse probability weight

The prevalence of interval censored data is increasing in medical studies due to the growing use of biomarkers to define a disease progression endpoint. Interval censoring results from periodic monitoring of the progression status. For example, disease progression is established in the interval between the clinic visit where progression is recorded and the prior clinic visit where there was no evidence of disease progression. A methodology is proposed for estimation and inference on the regression coefficients in the Cox proportional hazards model with interval censored data. The methodology is based on estimating equations and uses an inverse probability weight to select event time pairs where the ordering is unambiguous. Simulations are performed to examine the finite sample properties of the estimate and a colon cancer data set is used to demonstrate its performance relative to the conventional partial likelihood estimate that ignores the interval censoring.     

Combined survival analysis of cardiac patients by a Cox PH model and a Markov chain

The control and treatment of dyslipidemia is a major public health challenge, particularly for patients with coronary heart diseases. In this paper we propose a framework for survival analysis of patients who had a major cardiac event, focusing on assessment of the effect of changing LDL-cholesterol level and statins consumption on survival. This framework includes a Cox PH model and a Markov chain, and combines their results into reinforced conclusions regarding the factors that affect survival time. We prospectively studied 2,277 cardiac patients, and the results show high congruence between the Markov model and the PH model; both evidence that diabetes, history of stroke, peripheral vascular disease and smoking significantly increase hazard rate and reduce survival time. On the other hand, statin consumption is correlated with a lower hazard rate and longer survival time in both models. The role of such a framework in understanding the therapeutic behavior of patients and implementing effective secondary and primary prevention of heart diseases is discussed here.     

Simultaneous marginal survival estimators when doubly censored data is present

A doubly censoring scheme occurs when the lifetimes T being measured, from a well-known time origin, are exactly observed within a window [L, R] of observational time and are otherwise censored either from above (right-censored observations) or below (left-censored observations). Sample data consists on the pairs (U, δ) where U = min{R, max{T, L}} and δ indicates whether T is exactly observed (δ = 0), right-censored (δ = 1) or left-censored (δ = −1). We are interested in the estimation of the marginal behaviour of the three random variables T, L and R based on the observed pairs (U, δ). We propose new nonparametric simultaneous marginal estimators [^(S)]_T, [^(S)]_L{\hat S_{T}, \hat S_{L}} and [^(S)]_R{\hat S_{R}} for the survival functions of T, L and R, respectively, by means of an inverse-probability-of-censoring approach. The proposed estimators [^(S)]_T, [^(S)]_L{\hat S_{T}, \hat S_{L}} and [^(S)]_R{\hat S_{R}} are not computationally intensive, generalize the empirical survival estimator and reduce to the Kaplan-Meier estimator in the absence of left-censored data. Furthermore, [^(S)]_T{\hat S_{T}} is equivalent to a self-consistent estimator, is uniformly strongly consistent and asymptotically normal. The method is illustrated with data from a cohort of drug users recruited in a detoxification program in Badalona (Spain). For these data we estimate the survival function for the elapsed time from starting IV-drugs to AIDS diagnosis, as well as the potential follow-up time. A simulation study is discussed to assess the performance of the three survival estimators for moderate sample sizes and different censoring levels.     

Poisson regression with misclassified counts: application to cervical cancer

"Errors in disease classification can give misleading inferences for covariate effects when the probability of error is itself related to the covariates. More accurate inferences are possible using supplemental data on both true and fallible disease counts at various covariate levels. We present a method for incorporating such supplemental data into disease rate regression and use it to show that, although observed intercountry differences in European cervical cancer mortality rates are exaggerated by errors in death certification, they are not completely explained by such errors." The data concern Belgium, England and Wales, France, and Italy.     

Socio-economic re-structuring and employment: the case of minority ethnic groups

The consequences of major changes in employment, due to the decline of manufacturing and the growth of the service sector, have not been well-documented, nor theorized, in the sociology of ethnic relations, even in recent studies. For example, Blumer's classic argument that economic development adapts to 'race relations', rather than the reverse as predicted by the modernization school, has not been either empirically resolved or conceptually applied to the UK. By adapting data from the Labour Force Survey and the Census, the paper begins to fill this gap with a detailed account of three main minority ethnic groups, and a separate analysis of male and female employment. It is demonstrated that, contrary to assumptions that members of the minority ethnic groups suffered most from de-industrialization, they actually did rather well, and in some cases did better than the majority population. These findings are re-conceptualized as collective social mobility, as part of a review of a number of conceptual frameworks in the light of the data.